.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Accenture
US Army
QuintilesIMS
McKinsey
Deloitte
Boehringer Ingelheim
Baxter
McKesson

Generated: September 25, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Analogues of angiotensin II
Abstract:Novel hepta- and octapeptides of the formula: ##SPC1## Wherein R is hydrogen, succinyl, L-aspartyl, L-sarcosyl, L-seryl, succinamyl, or D- or L-asparaginyl and R.sub.1 is an L-alanine, L- or D-leucine, glycine or L-isoleucine residue upon intravenous infusion to animals inhibit blood pressure response to angiotensin amide.
Inventor(s): Sipos; Frank (Norwich, NY), Pals; Donald T. (Oxford, NY), Denning; George S. (Norwich, NY)
Assignee: Morton-Norwich Products, Inc. (Norwich, NY)
Application Number:05/043,595
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
AustriaA483471► Subscribe
Austria333986► Subscribe
Belgium767784► Subscribe
Canada940120► Subscribe
Switzerland555807► Subscribe
Germany2127393► Subscribe
Denmark145740► Subscribe
Spain391701► Subscribe
Finland53305► Subscribe
France2125248► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Queensland Health
US Department of Justice
Healthtrust
Julphar
UBS
AstraZeneca
Chinese Patent Office
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot